Depression (PHQ-9), anxiety (GAD-7), alcohol withdrawal (CIWA-Ar), and psychiatric assessment.
Detects domestic abuse (intimate partner violence) in pregnant and non-pregnant women in healthcare settings
Screens for adverse childhood experiences to assess risk of health problems in adulthood
UK alcohol units in a drink.
Screens and diagnoses adult ADHD based on DSM-IV-TR criteria using an 18-question self-report questionnaire
Identifies at-risk drinkers (i.e., binge drinking) who may not be alcohol dependent. A brief 3-question alcohol screen derived from the full AUDIT questionnaire.
Assesses substance use-related behaviors, risk factors, and protective factors over the past 30 days
Assess drug-induced akathisia severity.
Assesses alcohol withdrawal symptoms using 5 simple criteria: agitation, sweats, tremor, orientation, and hallucinations. A simplified alternative to CIWA-Ar that provides rapid assessment in clinical settings.
21-item self-report measure of anxiety severity (past week).
21-item self-report measure of depression severity (past 2 weeks).
Screens patients for agitation in emergency care and psychiatric settings using a 7-point observational scale
Brief Psychiatric Rating Scale: 18-item clinician-rated symptom severity.
Assesses severity of catatonia and screens for catatonia in psychiatric and neurological conditions. The first 14 items comprise the screening instrument. If 2 or more of the first 14 items are positive, this indicates a positive screening and should prompt completion of 9 additional items.
Screens for suicidal ideation and behavior to assess suicide risk and guide clinical management. The C-SSRS evaluates both the severity of suicidal ideation and the presence of suicidal behaviors, helping stratify patients into low, moderate, or high risk categories.
Screens for excessive drinking and alcoholism. The CAGE questionnaire is a 4-question screening tool used to help assess a patient's alcohol use and determine if they have an alcohol use disorder.
Assesses dysfunctional anxiety associated with the COVID-19 crisis through a brief 5-item self-report screening tool designed to identify individuals experiencing clinically significant coronavirus-related anxiety symptoms.
Clinical Global Impression - Severity scale.
Objectifies severity of alcohol withdrawal symptoms and guides treatment decisions
Identifies potential medication misuse in patients who are on long-term opioid therapy. The COMM is a validated self-report instrument for identifying and monitoring opioid misuse in chronic pain patients taking prescription opioids for pain management.
Quantifies severity of opiate withdrawal symptoms using 11 clinical criteria to guide treatment decisions and assess withdrawal progression
Brief 10-item assessment tool to measure, evaluate, and identify drug use problems, excluding alcohol and tobacco. Assesses drug use in the past 12 months.
13-item delirium severity scale (0-39).
Predicts compliance with opioid treatment for chronic non-cancer pain
Diagnostic criteria for binge eating disorder (BED) based on DSM-5. Evaluates presence of binge eating episodes, associated features, distress, frequency/duration, and exclusion criteria.
Diagnostic criteria for bipolar disorder based on DSM-5. Evaluates criteria for manic episodes, hypomanic episodes, and major depressive episodes to determine bipolar I, bipolar II, or other specified bipolar disorders.
Diagnostic criteria for major depressive disorder (MDD) based on DSM-5. Evaluates presence of core symptoms, duration, functional impairment, and exclusion criteria for major depressive episodes.
Diagnostic criteria for posttraumatic stress disorder (PTSD) based on DSM-5. Evaluates trauma exposure and four symptom clusters: intrusion, avoidance, negative alterations in cognitions/mood, and alterations in arousal/reactivity.
Screens for depression in the postnatal period through a validated 10-item self-report questionnaire. The most widely used postpartum depression screening tool worldwide, also valid for antenatal screening.
6-item nicotine dependence assessment.
Measures anxiety severity and screens for generalized anxiety disorder
Identifies possible depression in older adults aged 55 and older. The 15-item version is a brief, reliable screening tool that uses simple yes/no questions to assess depressive symptoms specific to the geriatric population over the past week
Clinical scale used to assess and monitor the severity of alcohol withdrawal symptoms. Evaluates five clinical characteristics (tremor, sweating, hallucinations, orientation, agitation) with scores from 0-2 each, for a total score ranging from 0-10 points. Used to guide benzodiazepine treatment dosing and monitoring intervals.
Clinician-rated 14-item scale quantifying severity of anxiety symptoms (psychic and somatic).
Clinician-rated 17-item scale quantifying severity of depressive symptoms.
Rates level of anxiety based on clinical questions. Assesses the severity of anxiety symptoms across 14 domains in patients already diagnosed with anxiety disorders.
Assesses severity of depression symptoms. The 17-item version is a clinician-administered scale that measures depressive symptoms over the past week.
Screens for pediatric mental health needs in the emergency department. Evaluates 7 domains: Home, Education/employment, Activities/peers, Drugs/alcohol, Suicidality, Emotions/behaviors, and Discharge resources.
7-item self-report of insomnia severity and daytime impact over the past 2 weeks.
9-point self-rating of current sleepiness.
Stratifies severity of depressive episodes in adults using 10 core mood symptoms, particularly sensitive to treatment-induced changes.
Screens for depression and provides both diagnosis and severity assessment using WHO-developed criteria
Mini-Mental State Examination (MMSE), prescored entry: enter the five domain subscores (orientation 0-10, registration 0-3, attention/calculation 0-5, recall 0-3, language/praxis 0-9); total 0-30 with standard severity bands.
Modified Dental Anxiety Scale (Humphris 1995): 5 questions scored 1-5 (not anxious → extremely anxious); total 5-25. Score ≥19 indicates high dental anxiety/phobia.
Scores symptoms for patients with alcohol withdrawal syndrome, particularly useful in critically ill patients and ICU settings
Morningness-Eveningness Questionnaire (Horne & Östberg 1976), prescored entry: enter the summed 19-item total (16-86). 16-30 definite evening, 31-41 moderate evening, 42-58 intermediate, 59-69 moderate morning, 70-86 definite morning.
Opioid Risk Tool (Webster 2005) for aberrant opioid behavior risk: gender-weighted items — family substance abuse (F3/M3), personal substance abuse (F4/M4), age 16-45 (1), preadolescent sexual abuse (F3/M0), psychological disease (F2/M2). Total: 0-3 low, 4-7 moderate, ≥8 high.
The PCS is a 13-item self-report scale of catastrophic thinking about pain (rumination, magnification, helplessness). Each item 0-4. Total 0-52; >=30 is clinically significant.
The PANSS is a 30-item clinician-rated scale for schizophrenia symptom severity. Each item 1 (absent) to 7 (extreme). Positive (P1-P7), Negative (N1-N7), General (G1-G16) subscales. Total 30-210.
Perceived Stress Scale 10-item (Cohen 1983): 10 items 0-4 (never to very often); items 4, 5, 7, 8 reverse-scored; total 0-40. 0-13 low, 14-26 moderate, 27-40 high perceived stress.
Perceived Stress Scale 14-item (Cohen 1983): 14 items 0-4; items 4, 5, 6, 7, 9, 10, 13 reverse-scored; total 0-56. Cutoffs ≤18 low, 19-36 moderate, ≥37 high (validated against thesis raw-data analysis).
The PHQ-2 is a 2-item depression screener (the first two PHQ-9 items). Each 0-3. Score >=3 is a positive screen for major depression.
The PHQ-9 is a 9-item self-administered questionnaire that scores each DSM criterion for depression from 0 (not at all) to 3 (nearly every day). Total score 0–27 grades depression severity and tracks response to treatment.
Global sleep quality from 7 prescored components (0-3 each). Global score > 5 indicates poor sleep quality.
Assesses depressive symptoms by self-report using 16 items covering the 9 DSM-IV depression criterion symptom domains. This validated instrument evaluates depression severity over the prior 7 days and is used for screening, monitoring treatment response, and research applications.
10-item suicide risk screen; each factor 1 point (0-10).
90-item symptom inventory (0-4 each): 9 subscales plus Global Severity Index (mean of all items).
5-item eating disorder screen; >= 2 positive answers suggests an eating disorder.
Yale-Brown Obsessive Compulsive Scale (Y-BOCS): 10 items (5 obsession, 5 compulsion), each 0-4. Total 0-40: 0-7 subclinical, 8-15 mild, 16-23 moderate, 24-31 severe, 32-40 extreme. Gold-standard OCD severity measure.
Young Mania Rating Scale (YMRS, Young 1978): 11 items rating manic symptoms over the prior 48 hours. Seven items scored 0-4 and four items (irritability, speech, thought content, disruptive-aggressive behavior) scored 0-8. Total 0-60: ≤12 minimal, 13-19 mild, 20-25 moderate, ≥26 severe.
Clinical Decision Support (CDS) Notice & Legal Disclaimer
All calculations and clinical scoring tools in this directory are intended strictly for educational and decision-support use by licensed medical practitioners. They do not constitute autonomous medical advice or direct treatment orders. See the full DexaMed Medical Disclaimer.